Reperfusion accelerates acute neuronal death induced by simulated ischemia.
Observations in real time can provide insights into the timing of injury and the mechanisms of damage in neural ischemia-reperfusion. Continuous digital imaging of morphology and cell viability was applied in a novel model of simulated ischemia-reperfusion in cultured cortical neurons, consisting of exposure to severe hypoxia combined with glucose deprivation, mild acidosis, hypercapnia, and elevated potassium, followed by return of oxygenated, glucose-containing physiological saline. Substantial acute injury resulted following 1 h of simulated ischemia, with 36+/-8% neurons dying within 2 h of reperfusion. Inclusion of moderate glutamate elevation (30 microM) in the simulation of ischemia increased the acute neuronal death to 51+/-6% at 2 h of reperfusion. While some swelling and neuritic breakdown occurred during ischemia, particularly with inclusion of glutamate, neuronal death, as marked by loss of somatic membrane integrity, was entirely restricted to the reperfusion phase. Morphological and cytoskeletal changes suggested a predominance of necrotic death in the acute phase of reperfusion, with more complete delayed death accompanied by some apoptotic features occurring over subsequent days. Prolonged simulated ischemia, without reperfusion, did not induce significant acute neuronal death even when extended to 3 h. We conclude that while morphological changes suggesting initiation of neuronal injury appear during severe simulated ischemia, the irreversible injury signaled by membrane breakdown is accelerated by the events of reperfusion itself.
Li
Dongdong
D
Department of Neurology, MC 2030, University of Chicago, 5841 S. Maryland Ave., Chicago, IL 60637, USA.
Shao
Zuohui
Z
Vanden Hoek
Terry L
TL
Brorson
James R
JR
D000142:Acidosis, Respiratory / Q000503:physiopathology; D000818:Animals; D017209:Apoptosis / Q000502:physiology; D016923:Cell Death / Q000502:physiology; D002462:Cell Membrane / Q000473:pathology; D002478:Cells, Cultured; D003599:Cytoskeleton / Q000473:pathology; D005947:Glucose / Q000172:deficiency; D018698:Glutamic Acid / Q000378:metabolism / Q000633:toxicity; D006935:Hypercapnia / Q000503:physiopathology; D020925:Hypoxia-Ischemia, Brain / Q000473:pathology / Q000503:physiopathology*; D051379:Mice; D008810:Mice, Inbred C57BL; D009336:Necrosis / Q000473:pathology / Q000503:physiopathology; D009410:Nerve Degeneration / Q000473:pathology / Q000503:physiopathology*; D009474:Neurons / Q000473:pathology*; D009498:Neurotoxins / Q000378:metabolism / Q000633:toxicity; D011188:Potassium / Q000378:metabolism; D015427:Reperfusion Injury / Q000473:pathology / Q000503:physiopathology*; D013997:Time Factors
D009498:Neurotoxins; D018698:Glutamic Acid; D005947:Glucose; D011188:Potassium